Search research articles
Contact Us
Filters
Showing results (11-20 of 97) with videos related to
Page
of 10
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science
|
June 4, 2002
Antipsychotics and sudden death: is thioridazine the only bad actor?
Wayne A Ray, Keith G Meador
The New England Journal of Medicine
|
January 13, 2006
Reform of drug regulation--beyond an independent drug-safety board
Wayne A Ray, C Michael Stein
American Heart Journal
|
February 28, 2002
Aspirin: redundant in users of nonaspirin, nonsteroidal antiinflammatory agents?
Wayne A Ray, Katherine T Murray
The New England Journal of Medicine
|
October 1, 2010
The ethics of placebo in studies with fracture end points in osteoporosis
C Michael Stein, Wayne A Ray
Statistical Methods in Medical Research
|
June 20, 2008
Use of disease risk scores in pharmacoepidemiologic studies
Patrick G Arbogast, Wayne A Ray
Psychiatric Services (Washington, D.C.)
|
October 5, 2007
Racial differences in antidepressant treatment preceding suicide in a Medicaid population
Wayne A Ray, Kathi Hall, Keith G Meador
Pharmacoepidemiology and Drug Safety
|
January 7, 2003
Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries
Wayne A Ray, Purushottam B Thapa, Patricia Gideon
Pharmacoepidemiology and Drug Safety
|
November 20, 2014
Performance of time-dependent propensity scores: a pharmacoepidemiology case study
Wayne A Ray, Qi Liu, Bryan E Shepherd
Clinical Pharmacology and Therapeutics
|
June 5, 2004
Postmarketing surveillance for drug safety: surely we can do better
Marie R Griffin, C Michael Stein, Wayne A Ray
The New England Journal of Medicine
|
May 9, 2003
Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy
Wayne A Ray, James R Daugherty, Keith G Meador
Page
of 10
Search research articles
Search
Showing results (11-20 of 97) with videos related to
Sort By:
Page
of 10
The British Journal of Psychiatry : the Journal of Mental Science
|
June 4, 2002
Antipsychotics and sudden death: is thioridazine the only bad actor?
Wayne A Ray, Keith G Meador
The New England Journal of Medicine
|
January 13, 2006
Reform of drug regulation--beyond an independent drug-safety board
Wayne A Ray, C Michael Stein
American Heart Journal
|
February 28, 2002
Aspirin: redundant in users of nonaspirin, nonsteroidal antiinflammatory agents?
Wayne A Ray, Katherine T Murray
The New England Journal of Medicine
|
October 1, 2010
The ethics of placebo in studies with fracture end points in osteoporosis
C Michael Stein, Wayne A Ray
Statistical Methods in Medical Research
|
June 20, 2008
Use of disease risk scores in pharmacoepidemiologic studies
Patrick G Arbogast, Wayne A Ray
Psychiatric Services (Washington, D.C.)
|
October 5, 2007
Racial differences in antidepressant treatment preceding suicide in a Medicaid population
Wayne A Ray, Kathi Hall, Keith G Meador
Pharmacoepidemiology and Drug Safety
|
January 7, 2003
Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries
Wayne A Ray, Purushottam B Thapa, Patricia Gideon
Pharmacoepidemiology and Drug Safety
|
November 20, 2014
Performance of time-dependent propensity scores: a pharmacoepidemiology case study
Wayne A Ray, Qi Liu, Bryan E Shepherd
Clinical Pharmacology and Therapeutics
|
June 5, 2004
Postmarketing surveillance for drug safety: surely we can do better
Marie R Griffin, C Michael Stein, Wayne A Ray
The New England Journal of Medicine
|
May 9, 2003
Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy
Wayne A Ray, James R Daugherty, Keith G Meador
Page
of 10